Napolitano, V.* ; Mroz, P.* ; Marciniak, M.* ; Kalel, V.C.* ; Softley, C. ; Janna Olmos, J.D.* ; Tippler, B.G.* ; Schorpp, K.K. ; Rioton, S. ; Fröhlich, T. ; Plettenburg, O. ; Hadian, K. ; Erdmann, R.* ; Sattler, M. ; Popowicz, G.M. ; Dawidowski, M.* ; Dubin, G.*
Structure-based design, synthesis and evaluation of a novel family of PEX5-PEX14 interaction inhibitors against Trypanosoma.
Eur. J. Med. Chem. 243:114778 (2022)
Trypanosomiases are neglected tropical diseases caused by Trypanosoma (sub)species. Available treatments are limited and have considerable adverse effects and questionable efficacy in the chronic stage of the disease, urgently calling for the identification of new targets and drug candidates. Recently, we have shown that impairment of glycosomal protein import by the inhibition of the PEX5-PEX14 protein-protein interaction (PPI) is lethal to Trypanosoma. Here, we report the development of a novel dibenzo[b,f][1,4]oxazepin-11(10H)-one scaffold for small molecule inhibitors of PEX5-PEX14 PPI. The initial hit was identified by a high throughput screening (HTS) of a library of compounds. A bioisosteric replacement approach allowed to replace the metabolically unstable sulphur atom from the initial dibenzo[b,f][1,4]thiazepin-11(10H)-one HTS hit with oxygen. A crystal structure of the hit compound bound to PEX14 surface facilitated the rational design of the compound series accessible by a straightforward chemistry for the initial structure-activity relationship (SAR) analysis. This guided the design of compounds with trypanocidal activity in cell-based assays providing a promising starting point for the development of new drug candidates to tackle trypanosomiases.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Chagas Disease ; Glycosomal Protein Import ; Hts ; Human African Trypanosomiasis ; Ppi Inhibition ; Structure-based Drug Design
Keywords plus
Language
english
Publication Year
2022
Prepublished in Year
HGF-reported in Year
2022
ISSN (print) / ISBN
0223-5234
e-ISSN
1768-3254
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 243,
Issue: ,
Pages: ,
Article Number: 114778
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
Amsterdam [u.a.]
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-503000-001
G-505293-001
G-506300-001
Grants
Narodowe Centrum Nauki
Bundesministerium für Bildung und Forschung
Fundacja na rzecz Nauki Polskiej
European Union's Framework Programme for Research and Innovation Horizon 2020
Copyright
Erfassungsdatum
2022-12-19